My watch list  

Evonik invests in start-ups

Evonik More Than Doubles Venture Capital to Accelerate Innovation


mohamed_hassan,, CC0

Evonik has launched its second venture capital fund with a volume of €150 million, more than doubling the amount under management to €250 million. The new fund will help secure access to disruptive technologies and innovative business models as well as supporting Evonik’s digital transformation and enabling early identification of potential technology acquisition targets.

“Investments in and partnerships with start-up companies generate strategic value and growth opportunities”, said Dr. Harald Schwager, Evonik’s deputy chairman of the executive board, who is responsible for innovation. “Our venture capital arm is a vital link to tomorrow’s technologies and way of doing business.”

The head of Evonik Venture Capital GmbH is Dr. Bernhard Mohr. “The extension of the fund volume to €250 million manifests our ambition to establish Evonik Venture Capital as one of the global leading investors in the specialty chemicals space”, said Mohr.

As well as providing capital, Evonik offers start-ups access to the resources of one of the world’s leading specialty chemicals companies. Since its inception in 2012, Evonik has realized 25 investments. The venture capital unit has a global reach with offices in Germany, U.S.A. and China. The investment focus is on business and innovation fields such as Health & Care, Animal Nutrition, Smart Materials and Specialty Additives, which Evonik has already identified as growth drivers.

The portfolio, which is made up of both direct and fund investments, includes companies such as Israeli digital-printing specialist Velox and the biotechnology start-up Numaferm, based in Dusseldorf. The portfolio company Structured Polymers, a U.S.-based business active in 3D-printing technology, was acquired by Evonik in early 2019.

Facts, background information, dossiers
  • Start-ups
  • venture capital
  • investments
More about Evonik
  • News

    Evonik reorganizes its polyamide business

    The specialty chemicals company has already begun construction of a new polyamide 12 (PA 12) facility complex and is expanding its production of transparent polyamides at the Marl Chemical Park, and, in so doing, is concentrating its activities on high-performance materials for attractive g ... more

    Evonik made a solid start to 2019

    Evonik made a solid start to the new year. Sales in the first quarter rose 1 percent to €3.29 billion compared to the prior-year quarter. Adjusted EBITDA declined 3 percent to €539 million. “In a weakening global economy we were able to hold our ground in terms of sales and earnings,” said ... more

    Evonik expands production capacities for transparent polyamides

    Due to increasing global demand for high-performance polymers, Evonik is expanding its production of transparent polyamides of the TROGAMID® CX brand at the Marl Chemical Park (Germany). Production expansion is scheduled for completion in the first quarter of 2020. The project will double t ... more

  • Job Offers

    Manager (m/f/div) Analytical Development Projects

    We don’t produce car tires, mattresses, tablets, or animal feed. However, these end products contain Evonik products – like 4,000 others, too. Often, it’s just a small amount that we contribute but that’s exactly what makes the difference. This is how Evonik makes tires more fuel-efficient, ... more

  • Companies

    Evonik Industries AG

    The Business Area Chemicals of Evonik which is active in the attractive field of specialty chemicals, holds top positions world wide. As Germany’s fifth largest power producer, Evonik is market and technology leader in the planning, construction and operation of highly efficient coal-fired ... more

    Evonik Technology & Infrastructure GmbH


    Evonik Industries AG


Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE